mRNA-1273
E1074406
UNEXPLORED
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Moderna COVID-19 vaccine | 1 |
| mRNA-1273 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T14008563 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: mRNA-1273 Context triple: [Moderna, developed, mRNA-1273]
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
C.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
mRNA vaccine
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: mRNA-1273 Target entity description: mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
C.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
mRNA vaccine
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
- F. None of above. chosen
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: mRNA-1273